Back
Edwards Lifesciences Quote, Financials, Valuation and Earnings
Sponsored
EW
Sponsored
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.
Sell
38
EW
Edwards Lifesciences
Last Price:
85.03
Seasonality Move:
8.41%
7 Day Trial
ALL ACCESS PASS
$
7
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the cornerEdwards Lifesciences Price Quote
$85.03
+0.73 (+0.87%)
(Updated: May 2, 2024 at 6:55 PM ET)
Edwards Lifesciences Key Stats
Sell
38
Edwards Lifesciences (EW)
is a Sell
Day range:
$83.50 - $85.73
52-week range:
$60.57 - $96.12
Dividend yield:
0%
P/E ratio:
36.65
P/S ratio:
8.34
P/B ratio:
7.14%
Volume:
2.2M
Avg. volume:
3.1M
1-year change:
-3.71%
Market cap:
$50.8B
Revenue:
$6B
EPS:
$2.32
How Much Does Edwards Lifesciences Make?
-
How Much Are Edwards Lifesciences's Sales Annually?
EW Revenues are $6B -
How Much Profit Does Edwards Lifesciences's Make A Year?
EW net income is $1.4B
Is Edwards Lifesciences Growing As A Company?
-
What Is Edwards Lifesciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.09% -
What Is Edwards Lifesciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.04%
Edwards Lifesciences Stock Price Performance
-
Did Edwards Lifesciences Stock Go Up Last Month?
Edwards Lifesciences share price went down by -10.56% last month -
Did EW's Share Price Rise Over The Last Year?
EW share price fell by -3.71% over the past 1 year
What Is Edwards Lifesciences 52-Week High & Low?
-
What Is Edwards Lifesciences’s 52-Week High Share Price?
Edwards Lifesciences has traded as high as $96.12 over the past 52 weeks -
What Is Edwards Lifesciences’s 52-Week Low Share Price?
Edwards Lifesciences has traded as low as $60.57 over the past 52 weeks
Edwards Lifesciences Price To Free Cash Flow
-
Is Edwards Lifesciences Stock Overvalued?
Edwards Lifesciences is trading at a price to free cash flow ratio of 203.95 -
Is Edwards Lifesciences Stock Undervalued?
Edwards Lifesciences EV to Free Cash Flow ratio is 198.12 -
What Is Edwards Lifesciences’s Price Earnings Growth Ratio?
EW PEG ratio is 0.00 -
Is Edwards Lifesciences Trading At A Premium To Earnings?
Edwards Lifesciences EV to EBIT ratio is 30.71
Is It Risky To Buy Edwards Lifesciences?
-
How Much Debt Does Edwards Lifesciences Have?
Total long term debt quarterly is $597.2M -
How Much Cash Does Edwards Lifesciences Have?
Cash and short term investments quarterly total is $1.7B -
What Is Edwards Lifesciences’s Book Value Per Share?
Book value per share is 11.82
Is Edwards Lifesciences Cash Flow Positive?
-
What Is EW Cash Flow From Operations?
Cash flow from operations (TTM) is $528.2M -
What Is Edwards Lifesciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$442.7M -
What Is Edwards Lifesciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is $236.4M
Edwards Lifesciences Return On Invested Capital
-
Is Management Doing A Good Job?
EW return on invested capital is 19.57% -
What Is Edwards Lifesciences Return On Assets?
ROA measures how assets are converting to revenues and is 15.33% -
What Is EW Return On Equity?
ROE is a measure of profitability and is 21.33%
Edwards Lifesciences Earnings Date & Stock Price
-
What Is Edwards Lifesciences's Stock Price Today?
A single share of EW can be purchased today for 84.30 -
What Is Edwards Lifesciences’s Stock Symbol?
Edwards Lifesciences trades on the S&P500 under the ticker symbol: EW -
When Is Edwards Lifesciences’s Next Earnings Date?
The next quarterly earnings date for Edwards Lifesciences is scheduled on July 26, 2024 -
When Is EW's next ex-dividend date?
Edwards Lifesciences's next ex-dividend date is May 3, 2024 -
How To Buy Edwards Lifesciences Stock?
You can buy Edwards Lifesciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Edwards Lifesciences Competitors
-
Who Are Edwards Lifesciences's Competitors?
Below is a list of companies who compete with Edwards Lifesciences or are related in some way:
Edwards Lifesciences Dividend Yield
Data Unavailable
Edwards Lifesciences Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 3.57% | 2.79% |
Revenue: | 9.5% | 1.68% |
Analyst Recommendations
Buy Recommendations: | 11 |
---|---|
Hold Recommendations: | 15 |
Sell Recommendations: | 1 |
Price Target: | 95.38 |
Upside from Last Price: | 13.14% |